Asthma
Conditions
Keywords
Asthma Advair
Brief summary
This study will compare patients treated with a marketed medication and those who continue with their usual care to assess the proportion of patients achieving well controlled asthma after 24 weeks.
Interventions
Sponsors
GlaxoSmithKline
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* documented clinical history of asthma and receiving regular maintenance therapy.
Exclusion criteria
* Using oral/parenteral or depot corticosteroids within 12 weeks of visit 1. * History of heavy smoking or substance abuse. * Females who are pregnant or lactating. * Required emergency room treatment for their asthma 12 weeks prior to Visit 1. * Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician. * Other medical criteria will be evaluated at the screening visit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients achieving well-controlled asthma at the end of the treatment period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of patients achieving total asthma control as defined by the Canadian Asthma consensus guidelines at the end of the treatment period. | — |
Countries
Canada
Outcome results
None listed